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Abstract
Multidrug-resistant Escherichia coli ST131 fimH30 responsible for extra-intestinal patho-
genic (ExPEC) infections is globally distributed. However, the occurrence of a subclone
fimH27 of ST131 harboring both ExPEC and enteroaggregative E. coli (EAEC) related
genes and belonging to commonly reported O25:H4 and other serotypes causing bacter-
emia in African children remain unknown. We characterized 325 E. coli isolates causing
bacteremia in Mozambican children between 2001 and 2014 by conventional multiplex poly-
merase chain reaction and whole genome sequencing. Incidence rate of EAEC bacteremia
was calculated among cases from the demographic surveillance study area. Approximately
17.5% (57/325) of isolates were EAEC, yielding an incidence rate of 45.3 episodes/105 chil-
dren-years-at-risk among infants; and 44 of isolates were sequenced. 72.7% (32/44) of
sequenced strains contained simultaneously genes associated with ExPEC (iutA, fyuA and
traT); 88.6% (39/44) harbored the aggregative adherence fimbriae type V variant (AAF/V).
Sequence type ST-131 accounted for 84.1% (37/44), predominantly belonging to serotype
O25:H4 (59% of the 37); 95.6% (35/44) harbored fimH27. Approximately 15% (6/41) of the
children died, and five of the six yielded ST131 strains (83.3%) mostly (60%; 3/5) due to
serotypes other than O25:H4. We report the emergence of a new subclone of ST-131 E. coli
strains belonging to O25:H4 and other serotypes harboring both ExPEC and EAEC
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virulence genes, including agg5A, associated with poor outcome in bacteremic Mozambican
children, suggesting the need for prompt recognition for appropriate management.
Author summary
Escherichia coli ST131 has emerged as a globally disseminated multi-drug resistant clone
associated with extra-intestinal infections acquired in the community or hospital. In Man-
hic¸a district, E. coli is among the top five leading bloodstream pathogens in children. We
characterized E. coli strains causing bacteremia in young children in a rural hospital of
Mozambique, providing novel information on the occurrence of a new subclone of ST131
harboring both ExPEC and EAEC related genes and belonging to commonly reported
O25:H4 and other serotypes. These data suggest the need for further understanding of
pathogenesis and clinical impact of this new entity to inform prompt recognition and
appropriate treatment.
Introduction
Escherichia coli is a common cause of community and hospital-acquired bacterial infection,
causing a wide range of clinical diseases and associated with high morbidity and mortality
worldwide [1,2]. Two major groups of pathogenic E. coli—diarrheagenic E. coli (DEC) and
extra-intestinal pathogenic E. coli (ExPEC)—are recognized, differing in their virulence factors
and associated clinical syndromes [2]. ExPEC strains are among the major causes of urinary
tract infections (UTI) and/or hospital/community-acquired bacteremia in both industrialized
[3,4] and low-income countries [4–6]. These strains differ from DEC or commensal E. coli
strains with respect to their virulence factors, with the former requiring specific attributes to
cause invasive disease, e.g. the ability to survive in serum, efficient iron uptake mechanisms
and internalization by the host [7].
In contrast, six well recognized pathotypes of DEC (enteropathogenic E. coli [EPEC], Shiga
toxin (Stx)-producing E. coli [STEC], enterotoxigenic E. coli [ETEC], enteroinvasive E. coli
[EIEC], enteroaggregative E. coli [EAEC] and diffusely adherent E. coli [DAEC]) [2], are
among the leading etiological agents of childhood [8,9] and travelers’ [10] diarrhea. Among
the ExPEC, a wide range of pathogenic lineages of E. coli have been reported, including
sequence type (ST) 131, among others [11,12]. ST131 firstly reported in the early 2000s, is a
globally disseminated multidrug resistant (MDR) clone with serious clinical impact [13–15],
particularly in Africa [12,16]. The most prevalent subclones of ST131 include fimH30 [14],
belong to serotypes O25:H4 and O16:H4 [13] is widely reported including clonal diversity
[16]. However, to our knowledge, the occurrence of ST131 subclone fimH27, exhibiting sero-
types different from O25:H4 or O16:H4 in addition to harboring EAEC genes (e.g. aggR and
AAF/V), remains obscure.
EAEC has long been regarded as an intestinal pathogen and therefore unlikely to cause dis-
ease in normal patients outside of the intestinal tract [17]. However, recent reports have linked
EAEC strains with urinary tract infection [18] and fatal hemolytic uremic syndrome [19] out-
breaks. The role of EAEC in extra-intestinal infections and associated outcomes among Afri-
can children admitted to hospitals, remains unknown. Through our ongoing invasive bacterial
disease surveillance, we previously documented E. coli as among the top five pathogens associ-
ated with community-acquired bacteremia in Mozambican children, with an associated case
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fatality ratio of nearly 10% [6]. Thus, assessing the molecular virulence markers of E. coli
strains circulating is an important first step in understanding the molecular epidemiology of
this entity in Mozambique, with the hope of informing appropriate control or prevention
strategies. Herein, we aim to characterize the molecular epidemiology of E. coli causing child-
hood bacteremia in a rural Hospital in Mozambique between 2001 and 2014.
Materials and methods
Ethics statement
Clinical data were routinely collected from an ongoing morbidity surveillance system in Man-
hic¸a district health facilities, established as part of CISM’s HDSS and approved by the Mozam-
bican Ministry of Health. All residents of the district of Manhic¸a have signed an individual
informed consent to become part of the ongoing HDSS established in the area.
Study population
The study was conducted by the “Centro de Investigação em Saúde de Manhiça (CISM)” at the
Manhic¸a District Hospital (MDH), the main referral health facility for the Manhic¸a district, a
rural area located 80 km north of Maputo, southern Mozambique. The district has an esti-
mated population of 183,000 inhabitants, and in this area, CISM has been running a continu-
ous health and demographic surveillance system (HDSS) since 1996, currently covering the
entire district’s population. A full description of the geographical and socio-demographic char-
acteristics of the study community has been presented elsewhere [20]. Of importance, HIV
sero-prevalence in the area is among the highest in the world (40% of the general adult popula-
tion) [21]. CISM is adjacent to the MDH, and since 1997, the hospital and CISM have jointly
operated a 24-hour surveillance of all pediatric (<15 years of age) visits to the outpatient
department and admissions to the wards including surveillance of invasive bacterial disease as
described previously [6].
Sample collection and laboratory procedures
As part of routine clinical practice at MDH, a single venous blood specimen for bacterial cul-
ture was systematically collected upon hospital admission for all children <2 years of age, and
for children aged 2 to<15 years with axillary temperature�39.0˚C or with signs of severe ill-
ness as judged by the admitting clinician for bacterial isolation as detailed described elsewhere
[6].
Detection of diarrheagenic E. coli pathotypes, phylogenetic groups and
virulence factors
Three hundred and twenty-five frozen E. coli isolates recovered from blood cultures were
retrieved, sub-cultured on MacConkey, and screened for the presence of EAEC, ETEC, EPEC,
and STEC markers by multiplex polymerase chain reaction (PCR) [22] including phylogenetic
group as described elsewhere [23]. Additionally, we tested the isolates for various ExPEC and
DEC virulence genes by conventional multiplex PCRs, targeting 44 genes including those com-
monly prevalent in EAEC (such as aggR, aatA, aap, aaiC and the recently discovered aar gene)
[24,25]. Positive samples were confirmed by sequencing five isolates for each gene of interest
in the Sequencing Core Facility of the University Of Virginia School Of Medicine, Charlottes-
ville, VA, USA.
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Antimicrobial resistance and mechanisms of resistance
The antimicrobial susceptibility phenotype for ampicillin, amoxicillin-clavulanic acid, cefurox-
ime, ceftriaxone, cefotaxime, aztreonam, ertapenem, imipenem, meropenem, nalidixic acid,
ciprofloxacin, chloramphenicol, amikacin, tobramycin, Gentamicin, Tetracycline and trimeth-
oprim-sulfamethoxazole (SxT) was determined by a conventional disk diffusion method on
Mueller Hinton agar [26] using commercially available disk (Oxoid, Basingstoke, Hampshire,
UK). The interpretative category of resistance was determined according to the Clinical Labo-
ratory Standard Institute (CLSI) guidelines [27]. Multidrug resistance was defined as resistance
to three or more unrelated antibiotic families and we considered non-susceptible isolates those
with an intermediate or full resistant profile [28]
Serotyping and whole genome sequence (WGS)
Somatic (O) and flagella (H) antigens were phenotypically identified using commercially avail-
able antisera as described elsewhere [29,30]. The following designations were included: ‘‘O
rough,” the boiled culture auto-agglutinated, suggesting absence of O antigen; ‘‘O?” when it
could not be determined whether the strain produces an O antigen (precipitation with Cetav-
lon indicates an acidic polysaccharide that could represent capsular K antigen); and ‘‘ONT,”
when the O antigen was found to be present but could not be typed. Serotyping was performed
on all bloodstream isolates positive for EAEC markers and a subset of other E. coli bacteremic
strains at the International Escherichia and Klebsiella Centre, Department of Bacteria, Parasites
and Fungi, Statens Serum Institut (SSI), Copenhagen, Denmark. Additionally, serotypes were
also assessed by WGS and compared to conventional serotyping.
Forty-four EAEC isolates (the total of positive by PCR) and 22 non-EAEC isolates for con-
trol purpose (randomly selected) were sequenced by using Illumina Miseq (Illumina, San
Diego, CA, USA). Briefly, Genomic DNA from isolates was purified using Qiagen DNeasy
Blood and Tissue kit (Qiagen, Valencia, USA) according to the kit protocol. Initial DNA con-
centrations were measured and quantified using Qubit Flourometer and dsDNA BR/HR
Assay Kit (Thermo Fisher Scientific). Sample and library preparation were performed using
the Nextera XT v2 DNA library Preparation Kit (Illumina, Sand Diego, USA). Libraries were
finally purified by Agencourt AMPpure XP System (Beckman Coulter, Indianapolis, USA).
WGS data were pre-processed employing a QC-pipeline (available at https://github.com/ssi-
dk/SerumQC), where isolate sequences were removed in case of contamination with more
than 5% of another genera, as well as sequences representing EAEC isolates with genome sizes
outside the range of 4.64 Mbp-5.56 Mbp. Isolate sequences were removed from the dataset if
assemblies comprised of more than 350 contigs. De novo assemblies were carried out using
CLC Genomics Workbench 10 with a minimum contig length of 200 bp. The genome size,
N50, and contigs are presented in S1 Table.
Sequence type, in silico serotype and virulence genes were determined from the de novo
assembled genomes using the webtools available at https://cge.cbs.dtu.dk/services/ [31]. The
least ambiguous phenotypical or in silico serotype was used in the final analysis i.e. non-motile
strains (H-) were given the in silico determined fliC H type, the in silico O type was used on O
rough and O? and the phenotypic O group was used if the in silico O type was ambiguous or
non-typeable.
Definitions
Bacteremia was defined as the isolation of at least one non-contaminant bacteria from the
blood culture collected on admission. Bacteremic EAEC strains were defined as isolates from
blood culture testing positive for one of the following genes: aggR, aaiC or aatA genes by
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multiplex PCR. Other bacteremic E. coli were defined as E. coli strains from blood culture
excluding EAEC, EPEC, ETEC and STEC.
Case fatality ratios (CFR), represent in-hospital mortality due to bacteremia calculated for
admitted children with known outcome (i.e. discharged alive, or dead), excluding patients that
left the hospital without medical permission or were transferred to Maputo Central Hospital as
previously described [6].
Statistical analysis
Statistical analyses were performed using STATA software, version 13.0 (Stata Corp., College
Station, TX, USA). The proportion of virulence factors found among children infected with
EAEC and other bacteremic E. coli was compared using Chi-squared or Fisher’s exact tests as
appropriate. Minimum community-based incidence rates (MCBIRs) for E. coli bacteremia
(EAEC and other bacteremic E. coli excluding ETEC and EPEC) were calculated referring
cases to population denominators establishing time at risk (child years at risk [CYAR])
inferred from the HDSS census information. Children did not contribute to the numerator or
denominator for a period of 15 days after each episode or when they were outside the study
area.
CART analysis was also performed, as previously described [24] (CART Pro Version 7.0;
Salford Systems). We included the collective number of virulence genes present (virulence fac-
tor score, VFS) in putting 48 factors of interest as binary (present/absent) independent predic-
tive variables along with a continuous ‘‘factor total” that was a sum of all factors including the
presence of malaria. Alive/death was the binary dependent outcome variable for isolates caus-
ing bacteremia. Furthermore, the CART analyses for bacteremic EAEC were also assayed for
66 genes assessed by WGS.
Results
Screening for EAEC markers, serotypes and phylogenetic groups
distribution
From January 2001 to December 2014, 37,536 blood cultures were collected from children
younger than 3 years of age admitted to the MDH; and 325 (0.8%) were positive for E. coli. Of
these, 57 (17.5%) met the definition of EAEC, 6 (1.8%) ETEC and 2 (0.6%) EPEC; while the
remaining 260 (80.0%) were classified as other bacteremic E. coli. Children with EAEC bacter-
emia appeared to be younger than those with bacteremia secondary to other E. coli [mean:
10.1 months (SD = 7.2) vs. 12.4 (SD = 8.3), p = 0.057], albeit not statistically significance.
Sixty-six (20.3%) [44 EAEC and 22 other bacteremic E. coli] of the 325 E. coli isolates were
serotyped, with serotype O25:H4 being the most frequent, accounting for 22 isolates (33.3%),
followed by O127:H4 with six (9.1%) isolates, and O51:H4 and O86:H4 with four (6.1%) iso-
lates each. All O25:H4, five of six O127:H4, and all O51:H4 and all O86:H4 were EAEC bacter-
emic E. coli isolates, followed by nine isolates (13.6%) of seven different serotypes (Table 1).
Virulence factors detected by conventional multiplex PCR
Of the 57 EAEC, detailed virulence factors were assessed in the 44 isolates serotyped and
sequenced. Of the 44 EAEC strains serotyped from blood, 41 (93.2%) met the definition of typ-
ical EAEC (presence of the master regulator gene, aggR) and were positive for aar (AggR- acti-
vated regulator). Only one typical EAEC (aggR+) strain lacked aatA while 37 showed the
combined presence of virulence genes aggR, aap, aatA and ORF3; and five and two isolates
lacked the aap or ORF3 genes, respectively. Table 2 shows the prevalence of virulence factors
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ST Fimtype Virulence genes AAF Phylogeny Age� Outcome Malaria Diarrhea Sex
C169-15 O125ab/O176:
H-
O176:H33• 10 H54 aaiC,astA,capU,gad,mchB,mchC,mchF,
mcmA,ORF3,ORF4,pic,sat, fyuA, hra,
iutA, agn43
Neg. A 10 Alive UNK Yes F
C194-15 O125ab/O176:
H-
O176:H33• 10 H54 aaiC,astA,capU,gad,mchB,mchC,mchF,
mcmA,ORF3,ORF4,pic,sat,fyuA, hlyA,
hra, iutA, agn43
Neg. A 12 Alive Yes No F
C190-15 O11:H- O11:H18• 31 Neg. aap,aar,aatA,aggA,aggB,aggC,aggD,
aggR,air,astA,eilA,gad,iha,iss,lpfA,ORF3,
ORF4,sat, fyuA, traT, papC, papA, hlyA,
hra, papGII, iutA, agn43
I B2 9 Alive Yes No F
C188-15 O153:H30 H30• 38 H5 aap,aar,aggA,aggB,aggC,aggD,aggR,
capU,eilA,gad,iss,nfaE,ORF3,ORF4,
fyuA, traT, hra, agn43





IV D 9 Alive Yes No M
C159-15 O25:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
papA, hlyA, hlyC, papGII, iutA, agn43
V B2 16 Alive No No M
C164-15 O25:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
cnf1,gad,iss,ORF3,ORF4, fyuA, traT,
papC, papA, hlyA, hlyC, aer, papGII,
iutA, agn43
V B2 13 Alive No No M
C166-15 Orough:H4 O127:H4• 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, hlyC, aer,
papGII, iutA, agn43
V B2 30 Alive Yes No M
C167-15 O25:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, hlyC, aer,
papGII, iutA, agn43
V B2 28 Alive No No M
C168-15 O?:H4 O51:H4• 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, papGII, iutA,
agn43
V B2 9 Alive No No F
C170-15 O25:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyC, papGII, iutA,
agn43
V B2 4 Dead No Yes M
C171-15 O25:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,gad,iha,iss,nfaE,ORF4,sat, fyuA,
traT, papC, papA, hlyA, hlyC, aer,
papGII, iutA, agn43
V B2 9 Alive Yes Yes M
C174-15 O86:H4 O86:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, hlyC, aer,
papGII, iutA
V B2 3 Alive Yes No M
C177-15 O25:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF4, fyuA, traT,
papC, papA, hlyA, hlyC, aer, papGII,
iutA, agn43
V B2 8 Alive No No M
C178-15 O25:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyC, aer, papGII,
iutA, agn43
V B2 9 Alive No Yes M
(Continued)
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ST Fimtype Virulence genes AAF Phylogeny Age� Outcome Malaria Diarrhea Sex
C179-15 O127:H4 O127:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,iss,ORF3,ORF4, fyuA, papA,
hlyA, hlyC, aer, papGII, iutA
V B2 7 Dead No No M
C182-15 O15:H4 O15:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,gad,iss,ORF3,ORF4, fyuA, traT,
papC, papA, hlyA, aer, papGII, iutA,
agn43
V B2 19 Alive No No M
C184-15 O25:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, hlyC, papGII,
iutA, agn43
V B2 7 Alive No No F
C185-15 O25:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF4,pic, fyuA, traT,
papC, papA, hlyA, hlyC, aer, papGII,
iutA, agn43
V B2 8 Transf. Yes No M
C189-15 O86:H4 O86:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, hlyC, aer,
papGII, iutA, agn43
V B2 32 Dead No No M
C191-15 O127:H4 O127:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,gad,iss,ORF3,ORF4, fyuA, traT,
papC, papA, hlyA, papGII, iutA, agn43
V B2 13 Left UNK Yes M
C193-15 O25:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,gad,iha,iss,ORF3,ORF4,sat, fyuA,
traT, papC, papA, hlyA, hlyC, aer,
papGII, iutA, agn43
V B2 6 Alive Yes Yes M
C197-15 O25:H- O25:H4• 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,iss,ORF3,ORF4, fyuA, traT,
papC, papA, hlyA, hlyC, aer, papGII,
iutA, agn43
V B2 16 Alive No Yes M
C198-15 O25:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, hlyC, aer,
papGII, iutA, agn43
V B2 5 Alive No Yes M
C199-15 O25:H4 O25:H4 131 H27 aap,aar,agg3B,agg3C,agg3D,agg5A,aggR,
cnf1,gad,iss,ORF3,ORF4, fyuA, traT,
papC, papA, hlyA, hlyC, aer, papGII,
iutA, agn43
V B2 3 Alive No Yes M
C200-15 O51:H4 O51:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, hlyC, papGII,
iutA, agn43
V B2 10 Alive No No M
C204-15 O86:H4 O86:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, hlyC, aer,
papGII, iutA
V B2 7 Dead No Yes M
C206-15 Orough:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, hlyC, aer,
papGII, iutA, agn43
V B2 7 Alive Yes Yes M
C207-15 O25:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,gad,iha,iss,mchB,mchC,mchF,
ORF3,ORF4,sat
V B2 1 Alive No Yes M
C209-15 O86:H4 O86:H4 131 H27 aap,aar,agg3B,agg3C,agg3D,agg5A,aggR,
gad,iss,ORF4, fyuA, traT, papC, papA,
hlyA, hlyC, aer, papGII, iutA
V B2 21 Alive Yes No M
(Continued)
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ST Fimtype Virulence genes AAF Phylogeny Age� Outcome Malaria Diarrhea Sex
C210-15 O?:H4 O51:H4• 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,gad,iss,ORF3,ORF4, fyuA, traT,
papC, papA, hlyA, hlyC, aer, papGII,
iutA, agn43
V B2 15 Alive UNK No M
C211-15 O25:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, hlyC, aer,
papGII, iutA, agn43
V B2 4 Dead Yes Yes M
C212-15 O25:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,gad,iss,ORF3,ORF4, fyuA, traT,
papC, papA, hlyC, aer, papGII, iutA,
agn43
V B2 10 Alive Yes Yes M
C213-15 O25:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, hlyC, aer,
papGII, iutA, agn43
V B2 8 Alive Yes No M
C215-15 Orough:H4 O127:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, aer, papGII,
iutA, agn43
V B2 22 Alive No No F
C216-15 O127:H4 O127:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, hlyC, aer,
papGII, iutA
V B2 10 Alive Yes No M
C217-15 O18ac:H4 O18ac:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, papGII, iutA,
agn43
V B2 1 Transf. No No M
C218-15 Orough:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, papGII, iutA, agn43
V B2 7 Alive No Yes M
C222-15 O25:H4 O25:H4 131 H27 aap,aar,aatA,agg3B,agg3D,agg5A,aggR,
gad,iha,iss,ORF4,sat, fyuA, traT, papC,
papA, hlyA, hlyC, aer, iutA, agn43
V B2 0 Alive No Yes M
C223-15 O51:H4 H4• 131 H27 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,gad,iss,ORF3,ORF4, fyuA, traT,
papC, papA, hlyA, hlyC, aer, papGII,
iutA, agn43
V B2 14 Alive No No M
C165-15 O25:H4 O25:H4 131 Neg. aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, hlyC, aer,
papGII, iutA, agn43
V B2 13 Alive Yes Yes M
C202-15 O25:H4 O25:H4 131 Neg. aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,cnf1,gad,iss,ORF3,ORF4, fyuA,
traT, papC, papA, hlyA, aer, papGII,
iutA, agn43
V B2 7 Alive UNK Yes M
C205-15 O166:H15 O166:H15 349 H93 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,air,capU,eilA,gad,iha,iss,ORF3,
ORF4,sat, traT, papC, papA, hlyA, hlyC,
aer, papGII, iutA, agn43
V D 5 Alive Yes No M
(Continued)
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comparing EAEC and other bacteremic E. coli isolates analyzed by conventional PCR. Notably,
35 out of 44 (79.5%) of EAEC isolates contained the three genes—iutA, fyuA and traT (associ-
ated with ExPEC) similar to 65% (100 isolates) of other bacteremic E. coli. The toxins com-
monly found in septicemic E. coli (e.g. hlyA, hylC and cnf1) were more prevalent among EAEC








ST Fimtype Virulence genes AAF Phylogeny Age� Outcome Malaria Diarrhea Sex
C219-15 O166:H15 O166:H15 349 H93 aap,aar,aatA,agg3B,agg3C,agg3D,agg5A,
aggR,air,capU,eilA,gad,iha,iss,ORF3,
ORF4,sat, traT, papC, papA, hlyA, hlyC,
aer, papGII, iutA, agn43
V D 8 Dead Yes No F
�Age in months; UNK–unknown; and REF- referred to Maputo central hospital; Transf.—Transferred
Definitions: papA, P fimbriae structural subunit; papC, P fimbria assembly; papGII, P fimbria adhesin; fimH, type 1 fimbriae; hra, heat-resistant agglutinin; hlyA, α-
hemolysin; hlyC hemolysin, cnf1, cytotoxic necrotizing factor; sat, secreted autotransporter toxin; pic, autotransporter protease; fyuA, yersiniabactin system; aer,
aerobactin; iutA, aerobactin receptor; traT, serum resistance associated; ibeA, invasion of brain endothelium; astA, EAEC heat-stable toxin; pet, Plasmid-encoded toxin;
sigA, IgA protease-like homolog; pic Serine protease precursor; sepA Shigella extracellular protease; ORF3 ORF4—Cryptic protein; aap, Dispersin, antiaggregation
protein; aaiC, AaiC secreted protein; aggR, EAEC transcriptional activator; aatA, Dispersin transporter protein; aggA, AAF/I major fimbrial subunit; aggB, minor
fimbrial subunit; aggC, usher; aggD, chaperone; agg4A, AAF/IV major fimbrial subunit; agg4B, minor fimbrial subunit; agg4C, usher; agg4D, chaperone; agg5A, AAF/V
fimbrial subunit; agg3B, minor fimbrial subunit; agg3C, usher; agg3D, chaperone; aar, AggR-activated regulator; eilA, Salmonella HilA homolog; capU,
Hexosyltransferase homolog; air, Enteroaggregative immunoglobulin; iss, increased serum survival gene, agn43; outer membrane protein; iha, adherence-conferring
protein; gad, Glutamate decarboxylase; mchB, mchC, mcmA, genes required for the production of the antimicrobial peptide microcin H47; mchF; microcin transporter
protein; nfaE, non-fimbrial adhesion the molecular serotype confirmed the conventional serotype except in seven strains (marked with •)
https://doi.org/10.1371/journal.pntd.0008274.t001
Table 2. Comparison of virulence factors of EAEC causing bacteraemia versus other bacteremic E. coli strains isolated in Mozambican children detected by conven-
tional multiplex PCR–EAEC associated virulence genes.
Virulence Gene Bacteraemic EAEC (N = 44)
n (%)




aatA 39 (88.6) 0 (0.0) <0.001
aaiC 2 (4.6) 0 (0.0) 0.044
aggR 41 (93.2) 0 (0.0) <0.001
aap 41 (93.2) 12 (7.3) <0.001
ORF3 39 (88.6) 10 (6.1) <0.001
ORF4 41 (93.2) 6 (3.7) <0.001
aar 41 (93.2) 44 (27.3) <0.001
astA 5 (11.4) 72 (43.9) <0.001
EAEC adhesins
aafC 0 (0.0) 22 (13.4) 0.005
agg3/4/5C 38 (88.4) 7 (4.2) <0.001
aggA 2 (4.5) 2 (1.2) NS
agg3A 0 (0.0) 0 (0.0) NS
aafA 0 (0.0) 3 (1.8) NS
agg4A 1 (2.3) 21 (12.8) 0.052
Agg5A 39 (88.6) 7 (4.3) <0.001
https://doi.org/10.1371/journal.pntd.0008274.t002
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Whole genome sequencing (WGS) of EAEC isolates
WGS data found that the 44 EAEC strains belonged to six different ST types with ST-131
accounting for 84.1% (37/44) of the strains, of which 35 (95.6%) harbor fimH27, while the
other two were negative for fimH typing. Furthermore, 59% (22/37) ST131 strains belonged to
the serotype O25:H4, while the remaining 41% (15/37) fall into five serotypes [O127:H4 (5
strains), O86:H4 (4), O51:H4 (4), O18ac:H4 (1) and O15:H4 (1)] (Table 1). Additionally,
93.2% (41/44) harbored the EAEC virulence plasmid pAA encoding the master regulator aggR
and several aggR- regulated genes, such as aap (dispersin), aatA (dispersin translocator), the
Table 3. Comparison of virulence factors of EAEC causing bacteraemia versus other bacteremic E. coli isolated in Mozambican children detected by conventional
multiplex PCR–ExPEC and miscellaneous associated virulence genes.
Virulence Gene Bacteremic EAEC (N = 44)
n (%)




sfaS 0 (0.0) 31 (18.9) 0.002
fimH 41 (93.2) 153 (93.3) NS
papA 43 (97.7) 96 (58.5) <0.001
papC 37 (84.1) 132 (80.5) NS
papGII 38 (86.4) 125 (76.2) 0.033
papGIII 1 (2.3) 3 (1.8) NS
afa_dra 3 (6.8) 63 (38.4) <0.001
Class I SPATEs
sat 1 (22.7) 31 (18.9) NS
pet 0 (0.0) 32 (19.5) 0.001
sigA 0 (0.0) 1 (0.6) NS
Class II SPATEs
sepA 1 (2.3) 19 (11.6) NS
pic 4 (9.1) 15 (9.2) NS
vat 3 (6.8) 59 (36.0) <0.001
epeA 0 (0.0) 0 (0.0) NS
eatA 0 (0.0) 3 (1.8) NS
Siderophores
iutA 41 (93.2) 144 (87.8) NS
iroN 0 (0.0) 67 (41.1) <0.001
fyuA 40 (90.1) 137 (83.5) 0.043
aer 30 (68.2) 127 (77.4) NS
Toxins
hlyA 36 (81.8) 50 (30.4) <0.001
hlyC 31 (70.5) 70 (42.7) <0.001
cnf1 27 (61.4) 58 (35.4) 0.002
hra 4 (9.1) 47 (28.6) 0.007
cdtb 0 (0.0) 0 (0.0) NS
agn43 38 (86.4) 26 (15.9) 0.017
Miscellaneous
air 4 (9.1) 33 (20.1) NS
eilA 5 (11.4) 85 (52.4) <0.0001
capU 5 (11.4) 35 (21.6) NS
ibeA 0 (0.0) 11 (6.7) NS
traT 38 (86.4) 131 (79.9) NS
https://doi.org/10.1371/journal.pntd.0008274.t003
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newly discovered aggR repressor aar [32], and the aggregative adherence fimbriae (AAF) gene
cluster. The AAF/V variant was found in 88.6% (39/44) of the EAEC strains followed by AAF/
I (2/44) and AAF/IV (1/44). The sequence analysis confirmed the PCR analysis and the pres-
ences of several ExPEC associated virulence genes (iutA, fyuA, traT, hlyA, hylC, cnf1, and pap-
GII). Furthermore, we found the increased serum survival gene—iss in 95.5% (42/44) of the
EAEC strains positive for aggR. Lastly, the molecular serotype confirmed the conventional
serotype except in seven strains (marked with • in Table 1). Additionally, virotype classifica-
tion did not provide a clear discrimination of our strains according to Dahbi et. al. [33], sug-
gesting possible occurrence of virotype E sub-type requiring further characterization of
isolates.
Antimicrobial susceptibility and associated mechanisms
We also assessed the antimicrobial resistance of the 44 EAEC strains, documenting high preva-
lence of resistance to the most commonly available and used antibiotic for empirical treatment
(ampicillin, gentamicin and chloramphenicol) in our community including multidrug resis-
tance (MDR) 97% as demonstrated in Table 4. WGS also identified genes conferring resistance
towards three or more groups of antibiotics; Aminoglycosides, Macrolides, Phenicols, Quino-
lones, Sulphonamides, Tetracyclines, Trimethoprim, and/or β-Lactams (Table 5).
Burden and clinical impact of EAEC bacteremia
Of the total of 325 E. coli bacteremia episodes, only 127 (39.1%) occurred in children living
within the DSS area, yielding an overall incidence rate of E. coli of 110.1 cases/100,000 child-
years (95%CI: 92.5–131.0) with the highest incidence occurring among infants (181.1 cases/
100,000 child-years; 95%CI: 143.7–228.1) (Table 6). EAEC incidence among infants was 45.3
Table 4. Antimicrobial susceptibility profile of EAEC causing bacteremia in young children in Manhic¸a District
Hospital.
Antibiotic name No. tested %R %I %S
Ampicillin 33 97 0 3
Amoxicillin/Clavulanic acid 33 21,2 33,3 45,5
Piperacillin/Tazobactam 31 0 0 100
Cefuroxime 33 0 36,4 63,6
Ceftazidime 33 0 0 100
Ceftriaxone 33 0 0 100
Cefoxitin 33 0 3 97
Aztreonam 33 3 0 97
Ertapenem 33 0 3 97
Imipenem 33 3 0 97
Meropenem 33 0 0 100
Amikacin 33 6,1 0 93,9
Gentamicin 33 48,5 0 51,5
Tobramycin 33 24,2 6,1 69,7
Nalidixic acid 33 3 3 93,9
Ciprofloxacin 33 18,2 0 81,8
Trimethoprim/Sulfamethoxazole 33 81,8 0 18,2
Chloramphenicol 33 72,7 0 27,3
Tetracycline 33 39,4 0 60,6
https://doi.org/10.1371/journal.pntd.0008274.t004
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C159-15 131 O25:H4 fimH27 B2 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C164-15 131 O25:H4 fimH27 B2 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2,tet(A)
C165-15 131 O25:H4 Negative A aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C166-15 131 O127:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2,tet(A)
C167-15 131 O25:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C168-15 131 O51:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2,tet(A)
C169-15 10 O176:H33 fimH54 A aadA1-like,blaOXA-1-like,catA1-like,strA,strB,sul2,tet(B)
C170-15 131 O25:H4 fimH27 B2 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C171-15 131 O25:H4 fimH27 B2 aac(3)-IId-like,aadA2,blaTEM-1B,catA1-like,dfrA12,mph(A),strA,strB-like,sul1,sul2
C174-15 131 O86:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C175-15 130 O17/O77:H34 fimH47 D Not found
C177-15 131 O25:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C178-15 131 O25:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C179-15 131 O127:H4 fimH27 A aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2,tet(A)
C182-15 131 O15:H4 fimH27 B2 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C184-15 131 O25:H4 fimH27 B2 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C185-15 131 O25:H4 fimH27 B2 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C188-15 38 H30 fimH5 D aadA1,blaTEM-1B,catA1-like,dfrA1,strA,strB,sul2,tet(D)
C189-15 131 O86:H4 fimH27 B2 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C190-15 31 O11:H18 Negative A blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2,tet(A)
C191-15 131 O127:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C193-15 131 O25:H4 fimH27 B1 aac(3)-IId-like,aadA2,blaTEM-1B,catA1-like,dfrA12,dfrA14-like,mph(A),strA-like,strB,sul1,sul2
C194-15 10 O176:H33 fimH54 A aadA1-like,blaOXA-1-like,catA1-like,strA,strB,sul2,tet(B)
C197-15 131 O25:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C198-15 131 O25:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C199-15 131 O25:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C200-15 131 O51:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C202-15 131 O25:H4 Negative B2 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C204-15 131 O86:H4 fimH27 B2 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C205-15 349 O166:H15 fimH93 B1 blaTEM-1B,strA,strB-like,sul2
C206-15 131 O25:H4 fimH27 D aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C207-15 131 O25:H4 fimH27 B2 aac(3)-IId-like,aadA2,blaTEM-1B,catA1-like,dfrA12,mph(A),sul1
C209-15 131 O86:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B
C210-15 131 O51:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2,tet(A)
C211-15 131 O25:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C212-15 131 O25:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C213-15 131 O25:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C215-15 131 O127:H4 fimH27 D aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C216-15 131 O127:H4 fimH27 A aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C217-15 131 O18ac:H4 fimH27 B1 aac(3)-IIa,aac(3)-IId-like,blaTEM-131-like,blaTEM-1B,catA1-like,dfrA7,floR-like,strA,strB,sul1-like,
sul2,tet(A)-like
C218-15 131 O25:H4 fimH27 B1 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2
C219-15 349 O166:H15 fimH93 A blaTEM-1B,dfrA8,strA,strB-like,sul2,tet(A)
C222-15 131 O25:H4 fimH27 B2 aac(3)-IId-like,aadA2,blaTEM-1B,catA1-like,dfrA12,sul1
C223-15 131 :H4 fimH27 B2 aac(3)-IId-like,blaTEM-1B,catA1-like,dfrA7,strA,strB,sul1-like,sul2,tet(A)
https://doi.org/10.1371/journal.pntd.0008274.t005
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cases/100,000 child-years (95%CI: 28.5–71.8), peaking in 2002 and 2003 with 71.5 and 78.9
cases/100,000 children-years, respectively (Fig 1).
Nutritional status was recorded for 51 of the 57 EAEC patients, of whom 8 (15.7%) were
severely malnourished, compared with 70/228 (30.7%) from other E. coli bacteremia group,
p = 0.031; and the CFR was similar in the two groups (15.8%, 9/57 vs. 14.7%, 38/258; p = 0.8,
for EAEC and other E. coli bacteremia, respectively). Fever (92.9% vs. 89.5%), diarrhea (42.1%
vs. 32.5%), vomiting (36.8% vs. 29.1%), and cough (71.9% vs. 73.3%) were found in similar pro-
portion between children infected with EAEC (n = 57) and other E. coli bacteremia (n = 258),
respectively.
The Classification and Regression Tree (CART) analysis suggests the presence of 2 clusters
associated with poor outcome in the absence of malaria. Cluster 1 comprising strains testing
positive for papGII and hra in the absence of sfaS (Node 1) and cluster 2 comprising strains
harboring cnf1 in the absence of hra and afa_dr (Node 2) (Fig 2). In addition, we demonstrated
the presence of fatal strains harbored hlyC and orf3 genes in the absence of agn43 (Node 1) or
belonging to ST131 clone harboring hlyA and aer lacking astA toxin (Node 2) among children
infected by EAEC (Fig 3). Case fatality ratio among children infected sequenced EAEC strains
was 14.6% (6/41), mostly related to ST131 strains (83.3%; 5/6); and 60% (3/5) children with
poor outcome were infected by serotypes other than O25:H4, namely O86:H4 (n = 2) and
O127:H4 (n = 1).
Classification and regression tree (CART) classification tree topology reveals combinations
of factors most strongly associated death in the absence of malaria (Fig 2) or for EAEC strains
(Fig 3). We considered all genotypic and phenotypic assays performed: aatA, aggR, aaiC, aap,
ORF3, sat, sepA, pic, sigA, pet, astA, aafC, agg3/4C, aafA, agg3A, aggA, agg4A, air, capU, eilA,
ORF61. Each branch of the CART tree ends in a terminal ’’node’’ (blue boxes), and each termi-
nal node is uniquely defined by the presence or absence of a predictive factor such as a gene.
The tree is hierarchical in nature.
Table 6. Minimum community-based incidence rates of Escherichia coli bacteemia among children aged less than 3 years living in Manhic¸a DSS study area, 2001–
2014.
Category Time-at-risk No. episodes Incidence rates a (95% CI)
Bacteremic EAEC
0–11 months 39767.38 18 45.3 (28.5–71.8)
12–23 months 38283.89 7 18.3 (8.7–38.4)
24–35 months 37309.93 3 8.04 (2.6–24.9)
All ages 115361.20 28 24.3 (16.7–35.2)
Other E. coli bacteremia
0–11 months 39766.1 54 135.8 (104.0–177.3)
12–23 months 38282.7 37 96.7 (70.0–133.4)
24–35 months 37309.7 8 21.4 (10.7–42.9)
All ages 115358.8 99 85.8 (70.5–104.5)
All bacteremic E. coli
0–11 months 39765.5 72 181.1 (143.7–228.1)
12–23 months 38282.5 44 114.94 (85.5–154.5)
24–35 months 37309.6 11 29.5 (16.3–53.2)
All ages 115357.5 127 110.1 (92.5–131.0)
a Incidence rates were calculated referring cases to population denominators establishing time at risk (child years at risk [CYAR]) inferred from the HDSS census
information. Children did not contribute to the numerator or denominator for a period of 15 days after each episode or when they were outside the study area.
https://doi.org/10.1371/journal.pntd.0008274.t006
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Discussion
This is the first study conducted in Mozambique characterizing E. coli strains causing child-
hood bacteremia; documenting the novel subclone of ST131 harboring EAEC genes causing
bacteremia in children, with its highest incidence peaking during infancy. During the last
years, evidence of involvement of non-fimH30 ST131 isolates and fimH30 subclone isolates
fulfilling molecular criteria for EAEC in extra-intestinal infections have been reported [18,34].
However, to our knowledge, this is the first report analyzing overtime trend incidences of
EAEC-associated bacteremia in African children, showing a magnitude similar to that caused
by Staphylococcus aureus or Hib (pre-vaccine introduction) in our population [6], suggesting
that EAEC is currently playing an important role as a cause of childhood E. coli bacteremia in
this setting.
The high incidence of EAEC reported here could either be related to pathogen or to host
factors, including malnutrition or HIV, both highly prevalent in our study area and also
known to enhance translocation of commensal bacteria to the bloodstream [2]. Despite the
limitation on HIV data in our study population, we believe that the EAEC incidence reported
here is possibly due to properties of the pathogen. If it was favored by HIV or malnutrition co-
Fig 1. Trends of minimum estimates of community incidence rates of E. coli bacteremia during the study period, 2001–2014.
https://doi.org/10.1371/journal.pntd.0008274.g001
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infection, we would expect to also find a high prevalence of the other pathotypes (e.g. EPEC or
ETEC) also prevalent among healthy children [35].
As a common enteric isolate, we hypothesize that extra-intestinal EAEC may arise via the
transfer the pAA plasmid more classical invasive pathogens, thus transferring additional viru-
lence traits. This is supported by the high prevalence of classical ExPEC virulence genes within
our EAEC, such as hlyA which is known to induce oxidative stress in blood [25], and which is
also associated with polymorphonuclear lysis/necrosis and lung injury in vivo in a rat model of
E. coli pneumonia [36]. The low prevalence of the chromosomal aaiC gene in our strains com-
pared to aggR and aatA on the pAA plasmid may be additional support for transfer of the pAA
plasmid. It also suggests that aaiC is not a good marker for EAEC bacteremic strains in our
community.
The high prevalence of adhesion AAF/V in our strains is noteworthy, suggesting a high
degree of phylogenetic relatedness of our strains. This is underscored by the presence of papC
or type 1 fimbriae (fimH) in more than 90% of isolates, suggesting that these strains may derive
from urinary tract infections (UTI) strains, despite the lack of clinical information with regard
to diagnosis of UTI. The change in fimH alleles might improve colonization abilities of the
Fig 2. Diagram of CART analysis against hospital outcome. We included the collective number of virulence genes present (virulence factor score, VFS) in putting 48
factors of interest as binary (present/absent) independent predictive variables along with a continuous ‘‘factor total” that was a sum of all factors including the presence of
malaria. We identified 2 clusters associated with poor outcome in the absence of malaria: i) comprising strains testing positive for papGII and hra_in the absence of sfaS
(node 1); and ii) comprising strains harboring cnf1 in the absence of hra and afa_dr (node 2).
https://doi.org/10.1371/journal.pntd.0008274.g002
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different clades (global dissemination of a multidrug resistant E. coli clone) [33], however, to
our knowledge this is second report of fimH27 subclade, which has recently been reported in
ST405 accounting for 13% of ExPEC strains isolated from clinical isolates in Nigeria [12]. In
contrast to the fimH30 subclade that is characterized to be resistant to extended spectrum of β-
lactamase or fluoroquinolones [15,37,38], our strains were susceptible to third generation
cephalosporines and fluoroquinolones. However, the resistance profile of our fimH27 strains
was similar to those reported by Roer et al from bloodstream infections in Denmark [39],
despite the high serotype- and ST diversity in the latter. Interestingly, the fact that the isolates
circulating in our community do not fit in the classical classification of virotypes [33] supports
the hypothesis of the presence of a new entity that require further characterization. Plasmid
analysis of our strains compared to globally disseminated fimH30 and fimH27 of ST405 is
underway and will be published elsewhere.
Also notable is the fact that WGS identified the presence of the iss gene, recognized for its
role in ExPEC virulence and considered a distinguishing trait of avian ExPEC but not of
human ExPEC [40], suggesting that some strains may fit in the classification of avian patho-
genic E. coli (APEC).
In addition, both serotyping and WGS data support the presence of serotype O25:H4 clone
ST131, a clone significantly associated with urinary tract infections and bacteremia [37]. More
interesting is the finding that 15 out of 37 (41.7%) of ST131 strains were from distinct sero-
types from the traditional O25:H4 and to our knowledge never previously reported: O127:H4
(5 strains), O51:H4 (4), O86:H4 (4), O18ac:H4 and O15:H4 [41,42]. EPEC has been shown to
cluster in related groups sharing the H antigen (H2 and H6) that differ only on the O antigen,
which might suggest that the LPS operon may be located in a phage region and can be trans-
ferred by transduction among EPEC [43]. Here, we find that these strains share H4 but differ
in their O antigen, yet belong to the same MLST type ST131, a finding that certainly warrants
further investigation. Importantly, E. coli phylogenetic analyses have generally attached greater
significance to the H antigen as a marker of shared genetic ancestry, suggesting that the high
preponderance of H4 strains in Mozambique may indeed signal the existence of a highly viru-
lent and longstanding pathogen. Further epidemiologic studies should address the importance
of H4 flagellar clones.
The WGS analysis illustrated that the recently discovered Aar, that has been hypothesized
to act directly or indirectly as a virulence suppressor, modulating virulence because of selection
towards clinical attenuation, was present in almost all isolates. These data may also strongly
support an important role for the aar gene in E. coli epidemiology; similar to what was found
in previous studies in Mali and Brazil where aar-negatives AAF/IV variant showed increased
pathogenicity [24,44].
Interestingly CART analysis data showed that deaths are likely to occur in the absence of
malaria; nearly 20% of such children died, of which 12 when infected with strains harboring
papGII and eight in those testing positive for hra (Fig 2, node 1). This finding reinforces the
need of routine screening of bacterial pathogens among children admitted in developing coun-
tries where most of deaths are attributable to malaria due to the limited microbiology infra-
structure. Indeed, fatal EAEC strains are also related to the presence or absence of specific
virulence factors found in ST131 strains (Fig 3) with attributable case fatality greater than that
caused by invasive non-typhoidal Salmonella [45] or S. aureus. In addition, despite the small
Fig 3. CART analyses for bacteremic EAEC assessing 66 genes by WGS. Regardless of age or serotype we demonstrated the
presence of fatal strains harboring hlyC and orf61 genes in the absence of agn43 (node 1) or belonging to ST131 clone harboring,
hlyA and aer lacking astA toxin (node 2).
https://doi.org/10.1371/journal.pntd.0008274.g003
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number of isolates, the poor outcome of ST131 non-O25:H4 serotypes may suggest that those
are more virulent that the classical serotype O25:H4, and require further in vitro or in vivo test-
ing to establish its potential virulence [13]. Unfortunately due to the lack of adequacy or
incomplete data on appropriate empirical treatment in terms of number of doses and days, the
variables of antimicrobial resistance, HIV treatment were not included in the CART analysis
which may help to elucidate the relationship of strains virulence profile and poor outcome
Our study sheds light on the etiology of the bacteremia events, suggesting that not only
O25:H4 EAEC, but also other previously undescribed EAEC serotypes of ST131 clone strains
can cause clinically severe invasive bacteremia in neonates and young children resulting in
hospitalization and death in Southern Mozambique, requiring prompt recognition for appro-
priate management.
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